Exactech Schedules Fourth Quarter and Year-End 2016 Earnings Release and Conference Call
February 13 2017 - 11:03AM
Business Wire
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products and biologic materials for
extremities, hip and knee will release its fourth quarter and
year-end 2016 financial results before the market opens on Tuesday,
February 21, 2017. A copy of the earnings release will be available
at http://www.hawkassociates.com.
The company will hold a conference call with CEO David Petty and
key members of the management team on the same day, Tuesday,
February 21 at 10:00 a.m. Eastern Time. The call will cover
Exactech’s fourth quarter and year-end 2016 results. Petty will
open the conference call and a question-and-answer session will
follow.
To participate in the call, dial 1-888-471-3836 any time after
9:50 a.m. Eastern on February 21. International and local callers
should dial 1-719-325-2475. A live webcast of the call will be
available at http://www.hawkassociates.com/profile/exac.cfm or
http://public.viavid.com/index.php?id=122940. This call will be
archived for approximately 90 days.
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech can be found
at http://www.exac.com.
A current investment profile on Exactech (Nasdaq: EXAC) is
available online at http://www.hawkassociates.com/profile/exac.cfm.
To receive future releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170213005757/en/
Exactech Inc.Investor contactsJody Phillips,
352-377-1140Executive Vice President of Finance & Chief
Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888EXAC@hawkassociates.comorExactech Inc.Media
contactsPriscilla Bennett, 352-377-1140Vice President, Corporate
& Marketing Communication
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Sep 2023 to Sep 2024